272 related articles for article (PubMed ID: 23818586)
1. Identification of a μ-δ opioid receptor heteromer-biased agonist with antinociceptive activity.
Gomes I; Fujita W; Gupta A; Saldanha SA; Negri A; Pinello CE; Eberhart C; Roberts E; Filizola M; Hodder P; Devi LA
Proc Natl Acad Sci U S A; 2013 Jul; 110(29):12072-7. PubMed ID: 23818586
[TBL] [Abstract][Full Text] [Related]
2. Molecular characterization of eluxadoline as a potential ligand targeting mu-delta opioid receptor heteromers.
Fujita W; Gomes I; Dove LS; Prohaska D; McIntyre G; Devi LA
Biochem Pharmacol; 2014 Dec; 92(3):448-56. PubMed ID: 25261794
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and Pharmacology of a Novel μ-δ Opioid Receptor Heteromer-Selective Agonist Based on the Carfentanyl Template.
Faouzi A; Uprety R; Gomes I; Massaly N; Keresztes AI; Le Rouzic V; Gupta A; Zhang T; Yoon HJ; Ansonoff M; Allaoa A; Pan YX; Pintar J; Morón JA; Streicher JM; Devi LA; Majumdar S
J Med Chem; 2020 Nov; 63(22):13618-13637. PubMed ID: 33170687
[TBL] [Abstract][Full Text] [Related]
4. Regulation of delta-opioid receptor trafficking via mu-opioid receptor stimulation: evidence from mu-opioid receptor knock-out mice.
Morinville A; Cahill CM; Esdaile MJ; Aibak H; Collier B; Kieffer BL; Beaudet A
J Neurosci; 2003 Jun; 23(12):4888-98. PubMed ID: 12832511
[TBL] [Abstract][Full Text] [Related]
5. Mu-opioid receptor knockout prevents changes in delta-opioid receptor trafficking induced by chronic inflammatory pain.
Morinville A; Cahill CM; Kieffer B; Collier B; Beaudet A
Pain; 2004 Jun; 109(3):266-273. PubMed ID: 15157687
[TBL] [Abstract][Full Text] [Related]
6. Antidepressant-like and anxiolytic-like effects following activation of the μ-δ opioid receptor heteromer in the nucleus accumbens.
Kabli N; Nguyen T; Balboni G; O'Dowd BF; George SR
Mol Psychiatry; 2014 Sep; 19(9):986-94. PubMed ID: 24061495
[TBL] [Abstract][Full Text] [Related]
7. Heteromers of μ-δ opioid receptors: new pharmacology and novel therapeutic possibilities.
Fujita W; Gomes I; Devi LA
Br J Pharmacol; 2015 Jan; 172(2):375-87. PubMed ID: 24571499
[TBL] [Abstract][Full Text] [Related]
8. Receptor heterodimerization leads to a switch in signaling: beta-arrestin2-mediated ERK activation by mu-delta opioid receptor heterodimers.
Rozenfeld R; Devi LA
FASEB J; 2007 Aug; 21(10):2455-65. PubMed ID: 17384143
[TBL] [Abstract][Full Text] [Related]
9. The µ-δ opioid heteromer masks latent pain sensitization in neuropathic and inflammatory pain in male and female mice.
Inyang KE; George SR; Laumet G
Brain Res; 2021 Apr; 1756():147298. PubMed ID: 33516809
[TBL] [Abstract][Full Text] [Related]
10. Differential response to morphine of the oligomeric state of μ-opioid in the presence of δ-opioid receptors.
Golebiewska U; Johnston JM; Devi L; Filizola M; Scarlata S
Biochemistry; 2011 Apr; 50(14):2829-37. PubMed ID: 21361347
[TBL] [Abstract][Full Text] [Related]
11. Agonists at the δ-opioid receptor modify the binding of µ-receptor agonists to the µ-δ receptor hetero-oligomer.
Kabli N; Martin N; Fan T; Nguyen T; Hasbi A; Balboni G; O'Dowd BF; George SR
Br J Pharmacol; 2010 Nov; 161(5):1122-36. PubMed ID: 20977461
[TBL] [Abstract][Full Text] [Related]
12. Antinociceptive effects of the 6-O-sulfate ester of morphine in normal and diabetic rats: Comparative role of mu- and delta-opioid receptors.
Yadlapalli JSK; Ford BM; Ketkar A; Wan A; Penthala NR; Eoff RL; Prather PL; Dobretsov M; Crooks PA
Pharmacol Res; 2016 Nov; 113(Pt A):335-347. PubMed ID: 27637375
[TBL] [Abstract][Full Text] [Related]
13. Activation of the Mu-Delta Opioid Receptor Heteromers Blocks Morphine Rewarding Effects.
Requana Aradas A; Djaboub Y; McCort-Tranchepain I; Hajasova Z; Clémenceau L; Canestrelli C; Mann A; Schulz S; Delaval A; Acher F; Massotte D; Noble F; Marie N
Int J Neuropsychopharmacol; 2023 Jul; 26(7):513-521. PubMed ID: 37343217
[TBL] [Abstract][Full Text] [Related]
14. μ-δ opioid receptor heteromer-specific signaling in the striatum and hippocampus.
Kabli N; Fan T; O'Dowd BF; George SR
Biochem Biophys Res Commun; 2014 Jul; 450(1):906-11. PubMed ID: 24976397
[TBL] [Abstract][Full Text] [Related]
15. Prolonged morphine treatment targets delta opioid receptors to neuronal plasma membranes and enhances delta-mediated antinociception.
Cahill CM; Morinville A; Lee MC; Vincent JP; Collier B; Beaudet A
J Neurosci; 2001 Oct; 21(19):7598-607. PubMed ID: 11567050
[TBL] [Abstract][Full Text] [Related]
16. Morphine-induced changes in delta opioid receptor trafficking are linked to somatosensory processing in the rat spinal cord.
Morinville A; Cahill CM; Aibak H; Rymar VV; Pradhan A; Hoffert C; Mennicken F; Stroh T; Sadikot AF; O'Donnell D; Clarke PB; Collier B; Henry JL; Vincent JP; Beaudet A
J Neurosci; 2004 Jun; 24(24):5549-59. PubMed ID: 15201327
[TBL] [Abstract][Full Text] [Related]
17. Ligand-directed trafficking of the δ-opioid receptor in vivo: two paths toward analgesic tolerance.
Pradhan AA; Walwyn W; Nozaki C; Filliol D; Erbs E; Matifas A; Evans C; Kieffer BL
J Neurosci; 2010 Dec; 30(49):16459-68. PubMed ID: 21147985
[TBL] [Abstract][Full Text] [Related]
18. The δ opioid receptor agonist SNC80 selectively activates heteromeric μ-δ opioid receptors.
Metcalf MD; Yekkirala AS; Powers MD; Kitto KF; Fairbanks CA; Wilcox GL; Portoghese PS
ACS Chem Neurosci; 2012 Jul; 3(7):505-9. PubMed ID: 22860219
[TBL] [Abstract][Full Text] [Related]
19. Receptor expression and signaling properties in the brain, and structural ligand motifs that contribute to delta opioid receptor agonist-induced seizures.
Blaine AT; van Rijn RM
Neuropharmacology; 2023 Jul; 232():109526. PubMed ID: 37004753
[TBL] [Abstract][Full Text] [Related]
20. Heteromerization of the μ- and δ-opioid receptors produces ligand-biased antagonism and alters μ-receptor trafficking.
Milan-Lobo L; Whistler JL
J Pharmacol Exp Ther; 2011 Jun; 337(3):868-75. PubMed ID: 21422164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
